That is very important, since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (legacy report prediction). Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a breakthrough practically nobody saw. However it's going to have profound implications for treating illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of financial investment opportunities in this space, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (tech stock). That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe substantially prior to going higher - jeff brown. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. tech predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of great private business on the brink of striking the public markets And I have actually been dealing with a new method for you to invest even prior to these companies go public.
This chance has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your spot totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (future report). And when it concerns tech investing, we leave it to the experts. Luckily, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing experts we understand (democratic republic). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing rapid development and developing amazing opportunities for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown biotech pick. But despite what numerous readers may think, this is a trend that's simply starting. Although the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (the legacy report predictions). Losing two months of production and sales actually impacts how many 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More notably, the hold-ups caused by the pandemic developed a lots of bottled-up demand. Which demand is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G devices will be shipped in 2021 - black sea. Which's not my only 5G forecast When I have actually talked about 5G in the past, I have actually explained its 3 various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage 3, 5G services start to be used (jeff brown stock picks 2021). That's when we start to see applications operating on 5G networks. Consider things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase Three by this summertime. This begins something of a virtuous cycle: Many people do not truly appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment opportunities going forward will be huge. Stepping away from 5G, the next important technology I visualize in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a comparable idea however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For several years, CRISPR was mainly a niche technology that wasn't well comprehended. And throughout that time, there were really just 3 companies running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're treating illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This entire market is effectively a greenfield chance.
There's room for many companies to exist in this space. last year. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is very important since the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been an experimental procedure. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug treatments produced using this technology. This was among those breakthroughs that practically nobody observed. But it's going to have extensive ramifications for treating disease. And, of course, there will be plenty of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly before going higher. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - social media. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date since February 2021, but we might not independently confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to choose winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an exceptional perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a number of his best picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully predicted a few of the most significant economic occasions of the past twenty years. Although he does not appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, however Jeff Brown's precise forecasts have made him legions of devoted followers. That says a lot about his capability. The Future Report is published by Brownstone Research study, a prominent financial research study publisher. Brownstone Research study uses numerous research study services with a broad variety of specializations - jeff brown stock picks 2021.
The company is also associated with Bonner & Partners, another well-respected research study publisher - genetic sequencing companies jeff brown. On its site, Brownstone states its mission is to offer retail investors with professional-grade research study: "For too long, the finest investment research has not been offered to specific financiers. It has been typically reserved for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown biotech stocks. The mission of Brownstone Research is to make that sort of exclusive research study offered to any financiers looking to get an edge in the marketplaces. The goal is easy to provide special and lucrative financial investment research study discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. angel investor. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown thinks S.A.V. tech predictions. might be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two innovative technologies: expert system and electric cars and trucks. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing brief of the automobile market's Holy Grail. As you understand, electric automobiles and self-driving vehicle stocks have actually been big this year, however the Wall Street machine has approved buzz without much concrete result. Regardless of an extreme increase in competitors over the previous few years, Brown still believes Musk has the best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transport. Essentially, this technology would enable you to rent out your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the automobile and press a button on an app that tells the vehicle to "join the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the earnings. It sounds outrageous, but it might be closed than you believe.